CD274 and non-small cell lung carcinoma: A multicenter, prospective cohort study of 196 samples (NSCLC, melanoma, RCC, and head and neck cancer) also supported that antibiotics reduce PD-1/PD-L1 response to treatment, and patients have lower OS [139].